Filter posts

2015 BIO CEO & Investor Conference™ Buzz of BIO Nominations Open

For the first time, the Buzz of BIO contest will take place at the 2015 …

2015 BIO CEO & Investor Conference™ to Feature Dynamic List of Company Presentations

Past and future attendees of the annual BIO CEO & Investor Conference have high expectations …

Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Invest...

The recent expansion and acceleration of the biotech stock market has seen a new willingness …

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug …

The Eyes Have It According to Recent VC Funding Patterns

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …

BIO 2015 Program Co-Chair Asks the Question - Will You Be A Change Agent?

In a recent blog post, Rob Wright of Life Science Leader challenges biotechnology, pharmaceutical, business …

Buzz of BIO winners at the 2014 BIO Investor Forum™

Buzz of BIO winners amongst the most innovative companies at the 2014 BIO Investor Forum™ …

BIO Latin America Program Highlights

BIO Latin America is just one short month away, September 9-11 in Rio de Janeiro, …

Buzz of BIO to recognize the most innovative companies at the 2014 BIO Investor Forum™

Nominations are now open for the Buzz of BIO at the 2014 BIO Investor Forum. …

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their …